Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Tempus AI, Inc. - Class A Common Stock
(NQ:
TEM
)
63.00
+4.29 (+7.31%)
Streaming Delayed Price
Updated: 9:57 AM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tempus AI, Inc. - Class A Common Stock
< Previous
1
2
Next >
Fabrinet Posts Strong Earnings, Joins Amer Sports, Hawaiian Holdings And Other Big Stocks Moving Higher On Tuesday
August 20, 2024
Via
Benzinga
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
August 20, 2024
The recent stock market dip provided some discounts.
Via
The Motley Fool
AST SpaceMobile And Rocket Lab Are Among Top 7 Best Performing Mid-Cap Stocks Last Week (Aug 11-Aug 17): Are The Others In Your Portfolio?
August 18, 2024
Seven mid-cap stocks soared last week, including ASTS, TEM, INTA, LOAR, RKLB, QFIN, and LITE. Have you added them to your portfolio?
Via
Benzinga
TEM Stock Earnings: Tempus AI Beats EPS, Beats Revenue for Q2 2024
August 17, 2024
TEM stock results show that Tempus AI beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Tempus AI Soars To New Highs, Investments From Google And SoftBank Boost Bullish Sentiment
August 16, 2024
Tempus AI stock is at all-time high of $47.81, up 17.27% since IPO in June. SoftBank invested $189 million in the company.
Via
Benzinga
Topics
Artificial Intelligence
Initial Public Offering
Exposures
Artificial Intelligence
Securities Market
7 Growth Stocks to Buy on Corrections for 3X Returns by 2026
August 15, 2024
These are the growth stocks to buy on corrections as they represent fundamentally strong companies with impending growth catalysts.
Via
InvestorPlace
NPJ Precision Oncology Publishes Tempus Study on Validation of its HLA-LOH Investigational Assay
August 08, 2024
From
Tempus AI, Inc.
Via
Business Wire
7 Growth Stocks That Could 7X in the Next 7 Years
August 08, 2024
Investors consider these growth stocks to buy since they represent companies with good fundamentals and a positive industry outlook.
Via
InvestorPlace
Tempus Reports Second Quarter 2024 Results
August 06, 2024
From
Tempus AI, Inc.
Via
Business Wire
Cathie Wood Buys $28 Million Of Amazon, Targets Crypto; Sells $26 Million Of This Stock
August 06, 2024
Cathie Wood bought the dip on Amazon stock, Coinbase, Robinhood, Meta and more. ARK Invest unloaded on tech names.
Via
Investor's Business Daily
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
August 06, 2024
The widely followed growth investor kicked off the new trading week by buying when others were selling.
Via
The Motley Fool
3 Under-The-Radar Healthcare Stocks to Buy for Outsized Returns
August 06, 2024
These under-the-radar healthcare stocks are on a high growth trajectory and represent companies that recently went public.
Via
InvestorPlace
3 AI-Powered Healthcare Stocks Transforming Medicine
August 02, 2024
Invest in AI healthcare stocks to benefit significantly from tech that could propel the healthcare market to $148.4 billion by 2029.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
7 New Growth Stock Listings That Can Be Long-Term Wealth Creators
August 02, 2024
These are the new growth stocks to buy as they represent under-the-radar companies with sustained growth potential
Via
InvestorPlace
Tempus Next Launches New Algorithm to Close Care Gaps in Guideline-Directed IHC Testing, Starting with HER2
August 01, 2024
From
Tempus AI, Inc.
Via
Business Wire
Tempus Announces Expanded Data and Sequencing Collaboration with Remix Therapeutics
July 30, 2024
From
Tempus AI, Inc.
Via
Business Wire
3 AI-in-Healthcare Stocks to Buy for Outsized Returns
July 29, 2024
These are the AI healthcare stocks to buy as they represent medical technology investing in research and development for accelerated growth.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
7 Growth Stocks That Can Create Millionaires by 2030
July 26, 2024
These are the millionaire-maker growth stocks to buy as they represent companies with good fundamentals and a big addressable market.
Via
InvestorPlace
Riot Platforms & North Face Parent V.F. Corp Are Among 11 Mid-Cap Stocks That Performed The Best Last Week (July 14-July 20): Are Others In Your Portfolio?
July 21, 2024
Top mid-cap stock performers: VIRT (+30%), VFC (+22%), NFE (+20%), RIOT (+16%), CLVT (+14%), AMN (+14%), BKU (+13%), MARA (+12%), EXPI (+12%), ZETA (+11%), NATL (+11%).
Via
Benzinga
7 Millionaire-Making Growth Stocks to Buy and Forget
July 18, 2024
These are the millionaire-maker growth stocks to buy for the long term as they represent quality companies in a big addressable market.
Via
InvestorPlace
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
July 18, 2024
A couple of the names you might not recognize -- yet.
Via
The Motley Fool
Tempus to Report Second Quarter 2024 Financial Results on August 6
July 17, 2024
From
Tempus AI, Inc.
Via
Business Wire
UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
July 16, 2024
Via
Benzinga
Tempus Expands Immuno-Oncology Portfolio with Launch of AI-enabled, Multimodal Immune Profile Algorithmic Tests
July 16, 2024
From
Tempus AI, Inc.
Via
Business Wire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
July 16, 2024
The popular growth investor keeps adding to some of her favorite falling stocks.
Via
The Motley Fool
3 Under-the-Radar IPO Stocks to Buy Before They Double
July 15, 2024
These are the under-the-radar IPO stocks to buy as they represent growth companies with an attractive business outlook.
Via
InvestorPlace
Topics
Initial Public Offering
Exposures
Securities Market
IPOs 2024: Tempus AI Addresses Medical Diagnostic Use Case
July 12, 2024
Tempus has been growing at a strong clip. Its revenues increased from $257.9 million in 2021 to $320.7 million in 2022 and to $531.8 million last year.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Investor That Backed Moderna Raises $3.6B For AI-driven Biotech Ventures
July 10, 2024
The funds are intended to launch a series of new biotech companies that will harness the power of generative artificial intelligence for drug discovery.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Tempus Surpasses 500 Research Publications
July 10, 2024
From
Tempus AI, Inc.
Via
Business Wire
Tempus AI Has Massive Market Opportunity For This Healthcare Technology, Bullish Analyst Says
July 09, 2024
William Blair initiated coverage on Tempus AI, highlighting its unique approach and business model in healthcare technology. The company, which leverages AI to analyze molecular, clinical, and genomic...
Via
Benzinga
Topics
Artificial Intelligence
Initial Public Offering
Exposures
Artificial Intelligence
Securities Market
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.